These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

658 related articles for article (PubMed ID: 5915720)

  • 1. Results of one-year chemotherapy with isoniazid (INH), streptomycin (SM) and ethionamide (ETA) in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J; Krychniak W; Krakówka P; Buraczewska M
    Pol Med J; 1966; 5(2):339-44. PubMed ID: 5915720
    [No Abstract]   [Full Text] [Related]  

  • 2. Results of one-year chemotherapy in previously untreated patients with cavernous pulmonary tuberculosis.
    Zajaczkowska J; Janczy S; Buraczewska M; Korlakowski J; Zych D; Krychniak W
    Pol Med J; 1966; 5(3):526-32. PubMed ID: 5920266
    [No Abstract]   [Full Text] [Related]  

  • 3. [Evaluation of alternative regimen of SM-INH-PAS and KM-TH-CS at three months interval in initial treatment of far advanced pulmonary tuberculosis. A report of the 12th series controlled trial of chemotherapy].
    Kekkaku; 1972 Jun; 47(6):151-8. PubMed ID: 5081204
    [No Abstract]   [Full Text] [Related]  

  • 4. [Analytic study of 80 cases of pulmonary tuberculosis treated with the INH-STRE-PAS regime during 1971-2].
    Chabbou A; Maalej M; Zbiba M; El Gharbi T; El Mekki L; Chebbi ML; Djenayah F; Ben Salah M; El Gharbi B; Jeguirim M; Cherif M
    Tunis Med; 1974; 52(6):305-11. PubMed ID: 4619936
    [No Abstract]   [Full Text] [Related]  

  • 5. [One-year results of initial therapy of cavernous pulmonary tuberculosis with isoniazid, streptomycin and ethionamide].
    Zajaczkowska J; Krychniak W; Krakówka P; Buraczewska M
    Gruzlica; 1965 Jul; 33(7):565-70. PubMed ID: 5849562
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical evaluation of Rifampicin in pulmonary tuberculosis. 2. A controlled trial on the clinical effects of chemotherapy with Rifampicin-INH-PAS and SM-INH-PAS for treatment of original cases of pulmonary tuberculosis].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1970 Aug; 45(8):257-62. PubMed ID: 4918166
    [No Abstract]   [Full Text] [Related]  

  • 7. [On qualitative demonstration of tuberculostatics in the control of taking of drugs].
    Grunert M; Reutgen H; Iwainsky H
    Z Tuberk Erkr Thoraxorg; 1965; 124(3):141-8. PubMed ID: 5899136
    [No Abstract]   [Full Text] [Related]  

  • 8. [The four-fold treatment of serious forms of pulmonary tuberculosis].
    Amsler R
    Sem Ther; 1966; 42(6):365-6. PubMed ID: 5984624
    [No Abstract]   [Full Text] [Related]  

  • 9. [Early and late results of massive antitubercular chemotherapy in previously untreated pulmonary tuberculosis in adults].
    Sosnowski W; Kubiak Z
    Gruzlica; 1972 Jan; 40(1):21-8. PubMed ID: 5011722
    [No Abstract]   [Full Text] [Related]  

  • 10. Ethionamide+cycloserine+pas vs isoniazid+streptomycin+pas in initial antiburerculosis chemotherapy followed by the standard regimen. A controlled study with special reference to the microscopic enumeration of bacillia as a criterion of efficacy.
    Pneumonologie; 1975; 151(3):167-84. PubMed ID: 1187376
    [No Abstract]   [Full Text] [Related]  

  • 11. Chemotherapy of tuberculosis.
    Lester W
    Clin Notes Respir Dis; 1970; 9(2):3-13. PubMed ID: 4319281
    [No Abstract]   [Full Text] [Related]  

  • 12. [Comparison of three regimens, INH-SM-PAS, INH-SM-RFP and INH-PAS-RFP, in the original treatment cases of pulmonary tuberculosis. Report of the 13th series study (original treatment study)].
    Kekkaku; 1973 Jun; 48(6):235-45. PubMed ID: 4581528
    [No Abstract]   [Full Text] [Related]  

  • 13. Cycloserine in the treatment of pulmonary tuberculosis.
    Aceves Ortega R; Cortés de la Peña F; Sanchez Ceceña S; Arreola Chavez C
    Scand J Respir Dis Suppl; 1970; 71():109-14. PubMed ID: 5271969
    [No Abstract]   [Full Text] [Related]  

  • 14. [Use of 4 antibacterial preparations in the treatment of destructive tuberculosis of the lungs].
    Volkon VM; Shrentsel' OA
    Probl Tuberk; 1973; 51(6):28-31. PubMed ID: 4202910
    [No Abstract]   [Full Text] [Related]  

  • 15. [Proceedings: Ambulatory chemotherapy of tuberculosis in Finland (organization)].
    Pätiälä J; Tani P
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):123-8. PubMed ID: 4128939
    [No Abstract]   [Full Text] [Related]  

  • 16. Tuberculous meningitis due to primary drug-resistant Mycobacterium tuberculosis hominis.
    Bonforte RJ; Karpas CM; Gribetz I; Shanzer S
    Pediatrics; 1968 Dec; 42(6):969-75. PubMed ID: 4973145
    [No Abstract]   [Full Text] [Related]  

  • 17. [Combined antitubercular treatment of pulmonary tuberculosis in adults].
    Böszörményi M
    Orv Hetil; 1970 Mar; 111(11):603-8. PubMed ID: 4911914
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical evaluation of intolerance to cycloserine.
    Baroni V; Foddai G; Lukinovich N; Pontiggia P
    Scand J Respir Dis Suppl; 1970; 71():217-9. PubMed ID: 4318440
    [No Abstract]   [Full Text] [Related]  

  • 19. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 20. [Duration of the after-control of the tuberculous patients following the termination of the treatment].
    Neumann G
    Wien Med Wochenschr; 1972 Dec; 122(51):764-8. PubMed ID: 4346497
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 33.